Abstract
Aims/hypothesis
We studied the impact of the reactive oxygen species hydrogen peroxide (H2O2) and antioxidative enzymes on the pathogenesis of diabetes induced by multiple low doses of streptozotocin (MLD-STZ).
Methods
We isolated the islets of C57BL/6 mice. For ex vivo analyses, mice had been injected with MLD-STZ. For in vitro analyses, islets were incubated with different concentrations of STZ, with either of the two moieties of STZ, methylnitrosourea and d-glucose, with H2O2 or with alloxan. Levels of H2O2 generation were measured by the scopoletin method. We assessed mRNA expression of Cu/Zn and Mn superoxide dismutase, catalase, and glutathione peroxidase (GPX) by semiquantitative polymerase chain reaction. GPX activity was measured spectrophotometrically. In vitro, beta cell function was assayed by measuring basal and d-glucose-stimulated release of immunoreactive insulin using an ELISA kit.
Results
Ex vivo, MLD-STZ significantly increased H2O2 generation in male but not in female mice. It also increased GPX activity and mRNA expression of catalase, Cu/Zn and Mn superoxide dismutase, and GPX in female but not in male mice. In vitro, STZ significantly stimulated H2O2 generation in islets of male mice only. In male islets, alloxan increased H2O2 generation at a highly toxic concentration, but d-glucose and methylnitrosourea did not. Both STZ and H2O2 dose-dependently inhibited the release of immunoreactive insulin after a d-glucose challenge.
Conclusions/interpretation
The results indicate that H2O2 participates in the pathogenesis of MLD-STZ diabetes in male C57BL/6 mice, which do not up-regulate antioxidative enzymes in islets. Conversely, female mice are protected, probably due to an increment of several enzymes with the potential to detoxify H2O2.
Similar content being viewed by others
Introduction
Type 1 diabetes is considered to be the result of a multifactorial process also involving T-cell-mediated inflammatory immune reactions [1, 2]. Reactive oxygen species (ROS) and nitrogen monoxide are implicated as mediators of beta cell destruction in animal models of diabetes [2, 3, 4]. There is substantial indirect evidence for the participation of ROS in the pathogenesis of diabetes, in particular the fact that the overexpression of antioxidants targeted at beta cells protects against the disease. Thus, overexpression of the superoxide radical (O2 −·)-scavenging enzyme, Cu/Zn superoxide dismutase (SOD), protects against alloxan-induced diabetes [5]; the hydrogen peroxide (H2O2)-converting enzyme, catalase, delays hyperglycaemia induced with one single high dose of streptozotocin (HD-STZ) [6]; the redox-active protein, thioredoxin, markedly reduces the cumulative incidence of spontaneous diabetes in non-obese diabetic mice and HD-STZ-induced diabetes [7]; and the ROS-scavenging protein, metallothionein, reduces HD-STZ-induced hyperglycaemia [8]. Lenzen et al. [9, 10, 11] have reported that overexpression of antioxidative enzymes in insulin-producing RINm5F cells also protects against oxidative stress. Their results clearly indicate that beta cells can counteract ROS by acquiring sufficient defence mechanisms, but direct measurements of ROS levels were not taken. Nevertheless, since insulin-producing cells appear particularly vulnerable to oxidative stress, probably due to their low levels of ROS-scavenging enzymes [12], their targeted overexpression may confer resistance.
In the putative Type 1 diabetes model induced with multiple low doses of streptozotocin (MLD-STZ) in male mice of susceptible strains, T-cell-dependent inflammatory immune reactions [13] are required subsequent to damage of the beta cell GLUT2 [14] for the disease to develop. Local production of pro-inflammatory cytokines [15] and activation of the transcription factors nuclear factor kappa B (NF-κB) and activator protein 1 [16] in isolated islets are associated with MLD-STZ diabetes. Pro-inflammatory cytokines may produce ROS [17], which activate the sensitive NF-κB [18] involved in gene activation of cytokines. These interactions may sustain chronic inflammatory processes. Hence, MLD-STZ diabetogenesis appears to involve more complex mechanisms than the capacity of STZ to alkylate DNA as reported for in vitro systems [19, 20]. Since we have already reported generation of ROS in pancreatic islets after incubation with STZ in vitro [21], we aimed in this study to elucidate the impact of local H2O2 generation and antioxidant responses in islets in MLD-STZ diabetogenesis.
Materials and methods
Animals
We obtained 5 to 6-week-old C57BL/6 mice of both sexes from Harlan Winkelmann (Borchen, Germany). Mice were 7 to 8 weeks old at the beginning of the experiments. They were kept under specific pathogen-free conditions and were given a rodent diet (ssniff diet for mice, Soest, Germany) and free access to drinking water. The animal studies were conducted in accordance with the “Principles of laboratory animal care” as well as with the current version of the German law on the protection of animals.
Materials
Collagenase (0.42 U/mg) and Tris were supplied by Serva (Heidelberg, Germany). d-glucose, catalase, scopoletin (7-hydroxy-6-methoxy-2H-1-benzopyrane-2-on, 6-methoxyumbelliferone), alloxan, methylnitrosourea, horse-radish peroxidase (HRP), glutathione peroxidase (GPX), EDTA, RPMI 1640 culture medium and H2O2 were purchased from Sigma (Deisenhofen, Germany). Penicillin-streptomycin was purchased from Gibco (Eggenstein, Germany), lymphocyte separation medium from Biochrom (Berlin, Germany), and FCS from Invitrogen (Karlsruhe, Germany). Reagents for KRB and t-butylhydroperoxide were supplied by Merck (Darmstadt, Germany). NADPH, glutathione, glutathione reductase and STZ were purchased from Roche Diagnostics (Mannheim, Germany), protein assay dye reagent was obtained from Bio-Rad (Munich, Germany), and the mouse insulin ELISA was purchased from Mercodia (Uppsala, Sweden).
Treatment of mice
To induce diabetes, mice were injected i.p. with MLD-STZ (5×40 mg STZ/kg body weight on 5 consecutive days) [22]. STZ was dissolved in 0.1 mol/l sodium citrate buffer (pH 4.0) at a concentration of 0.4% and injected within 5 min. Solvent-injected mice and MLD-STZ-injected female mice served as controls. Untreated mice were not included as controls, since previous studies have demonstrated that the results correspond to those obtained in solvent-treated mice [23]. By using solvent-injected control groups, non-specific effects due to i.p. injections are taken into account. Pancreatic islets were isolated from solvent-injected mice on day 3 after the final injection and from MLD-STZ-injected mice on day 1 and/or day 3 after the final injection. These time points were chosen because islets isolated from comparable treated groups did not differ significantly in number [24] and in total protein levels (µg/islet) [14]. An essential contribution of contaminating leukocytes as an H2O2 donor is excluded by using islets isolated on day 1 and/or day 3 after the final STZ injection. Any immune responses are only initiated, and mononuclear cell infiltrates, if at all present, are minimal [25].
Isolation and treatment of islets
Pancreatic islets were isolated by collagenase digestion as described previously [24], and cultured free-floating in RPMI 1640 medium containing 5.6 mmol/l d-glucose, 10% FCS, 100 U/ml penicillin and 0.1 mg/ml streptomycin in an atmosphere of 95% air and 5% CO2 at 37 °C for 2 h. To analyse H2O2 generation induced by MLD-STZ in vivo or STZ in vitro, groups of 150 islets were kept in 2700 µl KRB without BSA at 37 °C. To compare STZ-mediated H2O2 levels with the potent H2O2-generating compound, alloxan, islets were incubated with the latter diabetogen using concentrations equimolar to STZ. In vitro, islets were incubated with 1, 3, 6 or 10 mmol/l STZ or with 0.5, 1, 2, 4, 6 or 10 mmol/l alloxan at 37 °C for 30 min. STZ was dissolved in sodium citrate; alloxan was dissolved in saline (0.9%). Islets incubated with only the solvent served as controls. To investigate which of the two moieties of STZ induces H2O2 generation, islets were incubated with 1, 3 or 6 mmol/l methylnitrosourea or 1, 3, 6, 10 or 20 mmol/l d-glucose at 37 °C for 30 min. In these experiments, both substances were dissolved in sodium citrate buffer (pH 4.0). Islets treated with only the solvent served as controls. At the end of the incubation period, the supernatants were immediately removed and used for H2O2 analysis.
To test ex vivo effects of MLD-STZ or in vitro effects of STZ on GPX activity, groups of islets of 4 donor mice were isolated and pooled. For GPX activity measurements, 300 islets of the different experiments were homogenised. For ex vivo measurements, islets of MLD-STZ-injected mice of both sexes were isolated on day 1 and/or day 3 after the final injection. Islets of solvent-injected mice served as controls. In vitro, islet cultures were incubated with 6 mmol/l STZ at 37 °C for 30 min; solvent-treated cultures served as controls. To analyse the effects of H2O2 and STZ on beta cell function in vitro, islet cultures were set up for basal and glucose-stimulated release of immunoreactive insulin (IRI) as previously described [26] with slight modifications. Triplicates of 10 islets were suspended in 230 µl KRB in culture plates, and 20 µl of an H2O2 or STZ solution were added to obtain the required concentrations. Cultures supplemented with KRB, the solvent of H2O2, or sodium citrate, the solvent of STZ, served as controls. For measuring basal IRI, islets of each culture were transferred into 500 µl KRB and incubated at 37 °C for 60 min, and the medium was collected for measurement. For measuring stimulated IRI, islets were transferred to another well containing 480 µl KRB supplemented with a final concentration of 16.7 mmol/l d-glucose. They were then incubated for 60 min at 37 °C before the medium was collected for measurement. All medium samples were kept at −20 °C until IRI measurement.
Measuring H2O2
To investigate whether MLD-STZ-induced H2O2 generation is associated with diabetes, H2O2 levels were measured in islets ex vivo of MLD-STZ-injected diabetes-susceptible male mice and diabetes-resistant female mice. H2O2 levels were measured by the scopoletin method [27, 28]. Briefly, 20 µl HRP and 10 µl scopoletin were added to 2700 µl of the supernatant of an islet culture. In the presence of HRP, scopoletin is oxidised by H2O2 and loses its fluorescence capacity, which was continuously measured by excitation (350 nm) and emission spectra (460 nm) with a Perkin-Elmer LS-5 Luminescence spectrometer (Beckmann, DU 650, Munich, Germany) for 10 min. To test the effects of antioxidants on STZ-induced H2O2 generation, 20 µl of the H2O2-metabolising enzyme, catalase (1000 U/ml) were added to the supernatant immediately after the addition of scopoletin.
GPX assay
To study whether the sex-dependent MLD-STZ effects on H2O2 generation in islets are inversely correlated with the effects on antioxidative intracellular responses, GPX activities were measured in islets of MLD-STZ-injected mice of both sexes. GPX (Enzyme Commission 1.11.1.9) activity was assayed according to the instructions described by Paglia and Valentine [29] with slight modifications. Briefly, glutathione (1 mmol/l), NADPH (0.2 mmol/l) and glutathione reductase (0.6 U/ml) were dissolved in Tris-HCl/EDTA (50 mmol/l–5 mmol/l, pH 7.6). Tert-butyl hydroperoxide (0.22 mmol/l) was dissolved in deionised water. Homogenates of 300 islets were sonicated 3 times at 4 °C for 10 seconds in 1 ml Tris/EDTA buffer (Bandelin Sonoplus HD 60; Merck).
The reaction was started by adding 70 µl of the homogenate to 1050 µl of the Tris/EDTA buffer. The NADPH oxidation rate was recorded at 340 nm for 3 min and the enzyme activity was calculated as nmol NADPH oxidised·min−1·mg protein−1 using a molar extinction coefficient of 6.22×103·mol/l−1·cm−1. To measure total protein, 30 µl of the supernatant was used with a Bio-Rad protein assay kit.
RNA preparation and RT-PCR
To analyse whether the effect of MLD-STZ on antioxidative enzymes is systemic or at least preferential for pancreatic islets, the mRNA expression of Cu/Zn and Mn SOD, catalase, GPX1 and GPX4 was measured in liver specimens. Total RNA was extracted from pooled islets isolated from groups of 10 mice using the Trizol reagent kit (Life Technologies, Gaitherburg, Md., USA) [30]. The donor mice had been injected with MLD-STZ or its solvent. The RNA preparation was stored at −80 °C until use. By using Moloney murine leukaemia virus RT (Gibco), 1 µg of total RNA from islets was reversibly transcribed into cDNA, followed by the amplification of target genes by PCR. For the amplification of mouse Cu/Zn and Mn SOD, catalase, GPX1, GPX4 and the housekeeping gene, β-actin, as an internal control, primer pairs were commercially synthesised by MWG-Biotech (Ebersberg, Germany): Cu/Zn SOD 5′-ggacctcattttaatcctc-3′, 3′-tacacaggtaacttctagc-5′; Mn SOD 5′-tcaacgccaccgaggagaagta-3′, 3′-tggagtgagtgccggtgtaac-5′; catalase 5′-cgttttacatccaggtcat-3′, 3′-gactcttcggattcttgcg-5′; GPX1 5′-gcgaagtgaatggtgagaa-3′, 3′-aacagtggaaaacctatcg-5′; GPX4 5′-cgaattctcagccaaggacat-3′, 3′-ctcacaccaaatgcttaggac-5′; β-actin 540, 5′-gtgggccgctctaggcaccaa-3′, 3′-ctcttttagatgtcacgcacgatttc-5′; β-actin 795, 5′-aagtaccccattgaacatg-3′, 3′-gtacaagttaccccatgaa-5′. The RT reaction was amplified using Taq polymerase (Roche Diagnostics). The cycle numbers were chosen to be on the linear (exponential) phase of the amplification of the seven genes: 35 for catalase, Cu/Zn SOD, and GPX4; 30 for Mn SOD and β-actin 540; 43 for GPX1; and 22 for β-actin 795. For separation, 10 µg of the amplified PCR products were loaded on 1.5% agarose gels containing ethidium bromide (0.1 µg/ml). The resulting bands were quantified by Lumi-Analyst TM (Roche Diagnostics). To eliminate the possibility of genomic DNA contamination during RNA preparation, negative controls were set up for each PCR amplification using purified RNA as a template.
IRI measurement
Samples were analysed for IRI concentrations using an ELISA kit according to the manufacturer’s instructions.
Data analysis
Data are means ± SEM of at least three independent experiments. For PCR, intensities of bands of PCR products were measured using a Lumi-Imager. We calculated the ratio of the intensity integral of target PCR products to that of β-actin. For statistical analyses, the unpaired Student’s t test was applied. We considered a p value of less than 0.05 to be statistically significant.
Results
Effect of MLD-STZ on H2O2 generation
Significantly increased H2O2 levels (p<0.05) were obtained on day 3 after the final STZ injection in islets of male mice only, compared with the results of solvent-injected controls (Fig. 1). In islets of female mice, H2O2 was not generated by MLD-STZ. The H2O2 levels were similar in islets of solvent-injected control groups of both sexes. Thus, MLD-STZ stimulates H2O2 generation in islets of diabetes-susceptible male mice only.
Effect of MLD-STZ on GPX activity
As shown in Figure 2, in islets of male mice, the GPX activity was significantly reduced by MLD-STZ on day 1 after the final injection compared with the solvent-injected controls (p<0.001). On day 3 after the final injection, the activity was comparable to that of the control islets. However, in islets of female mice, MLD-STZ stimulated GPX activities significantly on day 3 after the final STZ-injection (p<0.01). Furthermore, on day 1 after the final STZ-injection, the GPX activity was significantly higher in female mice than in male mice (p<0.001), which had reduced GPX activity. Thus, resistance against MLD-STZ-induced H2O2 generation and diabetes is associated with the up-regulation of GPX activity, which detoxifies H2O2 to H2O and O2.
Effect of MLD-STZ on cellular antioxidative enzymes
The resistance of female mice to MLD-STZ diabetes may rely upon the up-regulation of several antioxidative enzymes. As illustrated in Figure 3, in islets of MLD-STZ-injected male mice, the levels of mRNA expression of Cu/Zn and Mn SOD, catalase, GPX1 and GPX4 did not significantly change on day 1 and day 3 after the final injection compared with solvent-injected controls. In contrast, in islets of female mice, MLD-STZ significantly stimulated up-regulation of all five enzymes. MLD-STZ did not affect the levels of these five enzymes in liver specimens (shown for Mn SOD as an example in Fig. 4).
Effect of STZ exposure on H2O2 generation
Incubation of islets of male donor mice with different concentrations of STZ resulted in dose-dependent H2O2 generation compared with solvent-incubated control cultures (Fig. 5). Significant H2O2 generation (p<0.01) was already measured after incubation with 1 mmol/l STZ; the highest level was obtained with 6 mmol/l STZ (7.31±1.41 µmol/l H2O2). Incubation with 10 mmol/l STZ did not stimulate significant H2O2 generation. In contrast, in islets of female mice, significant H2O2 generation (p<0.05) developed after incubation with 6 mmol/l STZ only, yet this H2O2 level remained significantly below the levels in islets of male mice exposed to 3 or 6 mmol/l STZ. Thus, STZ stimulated H2O2 generation in islets of male mice most effectively, and probably required biochemical chain reactions, which were inhibited by the toxic effects of 10 mmol/l STZ. The specificity of H2O2 generation was assessed by adding catalase to the supernatant of islet cultures incubated with 6 mmol/l STZ, which gave the highest H2O2 level. Catalase completely inhibited H2O2 generation, presumably through enzymatic inactivation.
Incubation of islets with the two moieties of STZ, methylnitrosourea and d-glucose, did not stimulate H2O2 generation (Fig. 6a, b). Clearly, transportation of STZ into beta cell compartments by GLUT2 is required for H2O2 generation. A significant H2O2 generation (p<0.05) was only obtained after incubation with 10 mmol/l alloxan (Fig. 6c), which, although markedly lower, did not differ significantly compared with the highest level induced with STZ (6 mmol/l). Note that 10 mmol/l of both STZ and alloxan are highly toxic and result in immediate beta cell destruction. The differences in the control cultures are probably due to variabilities inherent to complex methods and multifactorial systems.
Effect of STZ exposure on GPX activity
Islets of both sexes were incubated with 6 mmol/l STZ or with the solvent as controls. STZ significantly reduced the GPX activity in islets of male mice (p<0.01); the levels decreased from 29.54±5.9 to 11.44±1.9 mU/mg protein. In contrast, in islets of female mice, STZ significantly increased the GPX activity from 22.94±1.52 to 50.93±9.05 mU/mg protein (p<0.001; Fig. 7).
Effect of exposure to STZ and H2O2 on IRI release
As expected, solvent-incubated islets of male mice responded upon d-glucose challenge with a significantly increased (p<0.05) mean stimulation index (ratio of d-glucose-stimulated IRI to basal IRI) of 10.7±1.1 (Fig. 8a) and 5.2±1.7 (Fig. 8b). Incubation with STZ (Fig. 8a) or H2O2 (Fig. 8b) at the concentrations indicated resulted in higher basal IRI release compared with solvent-incubated control cultures. Challenge with d-glucose did not stimulate significant changes. Similar results were obtained in islets of female mice (data not shown).
Discussion
The present data are the first to demonstrate that MLD-STZ diabetes is associated with local generation of H2O2 in pancreatic islets, which is probably due to insufficient levels of antioxidative enzymes. MLD-STZ stimulated H2O2 generation in islets of diabetes-susceptible male C57BL/6 mice, and did not change levels of mRNA expression of the antioxidants Cu/Zn and Mn SOD, catalase and the GPX isoforms 1 and 4. Furthermore, a transient reduction of GPX activity resulted from MLD-STZ injections. Completely reversed MLD-STZ effects were induced in islets of diabetes-resistant female mice. MLD-STZ did not stimulate H2O2 generation, but it increased mRNA in all five antioxidative enzymes as well as increasing GPX activity. The local MLD-STZ effects described in islets are presumably organ specific, as MLD-STZ failed to affect the mRNA expression in liver specimens of both sexes. Thus, our data emphasise the presumed impact of cytoprotective enzymes in beta cell defence mechanisms against ROS. They also support studies demonstrating resistance to diabetes in bioengineered mice that overexpress antioxidative enzymes targeted at beta cells [6, 7, 8]. Moreover, our ex vivo results are consistent with several in vitro findings indicating that insulin-producing cells transfected with ROS-inactivating enzymes combat damage induced by oxidative stress [9, 10, 11]. However, the effect on local ROS generation has not been measured in islets of transgenic mice or transfected insulin-producing cells overexpressing antioxidants.
Our data are the first to relate MLD-STZ-induced H2O2 generation to diabetes susceptibility. This observation is important because it strengthens assumptions described previously by this laboratory [21]. Briefly, in vitro, STZ stimulates generation of hydroxyl radicals (·OH), the most toxic species of the group of ROS, in isolated islets. In the cascade of ROS generation, H2O2 is required to promote the formation of ·OH in the presence of Fe++, which can catalyse the Fenton reaction to convert H2O2 into ·OH and H2O. Thus, the sequence of reactions stimulated by STZ in vitro may reflect similar interactions in vivo. In addition, there is indirect evidence for mitochondrially derived ROS formation, as the very marked up-regulation of Mn SOD in islets of MLD-STZ-injected female mice may reflect efficient metabolisation of O2 −· resulting from respiratory chain reactions.
To generate H2O2, both moieties of STZ are required, since neither methylnitrosourea nor d-glucose alone does so. Thus, specific direction of STZ to the beta cells and transportation into intracellular compartments by the facilitative GLUT2 is essential for the stimulation of the deleterious signal cascade [14, 31]. Presumably, the diabetogenicity of STZ in the MLD-STZ system is determined by ROS generation, as STZ and methylnitrosourea are similar alkylating agents in vitro [19, 32], but methylnitrosourea is not diabetogenic [20]. Moreover, the alkylating potential of STZ in the MLD-STZ system remains to be shown.
Assessing the mRNA expression of Cu/Zn and Mn SOD, catalase, GPX1 and GPX4, Tiedge et al. [12] found expression of Cu/Zn and Mn SOD, as well as of GPX4 but not of GPX1 in isolated rat islets, and expression of Cu/Zn and Mn SOD and catalase, but not of GPX1 and GPX4 in RINm5F cells. In contrast, we found gene expression of all five antioxidative enzymes in murine islets ex vivo. Therefore, the activity of GPX1 in rat islets described by Tiedge et al. [12] is supported by our data showing its gene expression. Whether the described differences are species dependent and modulate susceptibility to STZ remains to be tested. Concerning the translation of RNA levels into activities, we assume that the reduced and increased RNA levels of the present study reflect diminished and augmented protein activities respectively. This is similar to our findings regarding GPX activity, as described above, and to recent reports demonstrating that RNA levels determine enzyme activities, as observed for CuZn and Mn SOD, catalase and GPX, and are usually translated into activities [11, 12].
Whether the slight increase of catalase and GPX1 in male mice is biologically efficacious remains to be resolved.
The generation of ROS by MLD-STZ is probably involved in the development of diabetes. Although STZ is not an ROS generator as such, it may interact with islet cell components in a way that triggers the cascade of ROS formation. In vitro, STZ stimulated O2 −· generation in the presence of the xanthine oxidase system [32] and in isolated submitochondrial particles [21]. This enhanced O2 −· generation activates the vicious cycle of the complex molecule interactions in the cascade of ROS formation. In islets of male mice, an imbalance develops in favour of ROS, which may damage beta cell structures. Female mice, on the other hand, can cope with this oxidative stress through antioxidative enzyme responses, preventing damage to their beta cells. It is assumed that the inversed MLD-STZ-induced responses of oxidants and antioxidants are regulated by the sex-determining hormones. The experimental design to test this assumption would be to study the effect of acute pre-treatment of male and female mice with oestradiol and testosterone respectively, and to perform long-term sexual changes by castration and ovarectomy. Such experiments would complement those demonstrating sex-dependent susceptibility to MLD-STZ diabetes [34, 35]. The results could further elucidate the impact of ROS in MLD-STZ diabetogenesis.
Once available, ROS may activate the transcription factor NF-κB in islets [16], which is involved in gene activation of pro-inflammatory cytokines [36], and it may sustain local inflammatory reactions. In the group of ROS, H2O2 was shown to be an activator of NF-κB [37]. Thus, depending on the type of reaction, cells can respond to ROS with antioxidative, protective activities, or can use them as second messengers in signal transduction [17, 38].
Finally, the unexpected in vitro data are discussed, which indicate similar responses in basal and d-glucose-stimulated IRI release in islets of both sexes. We propose that the STZ- and H2O2-stimulated IRI results are caused by passive leakage due to immediate effects, damaging other beta cell structures in addition to GLUT2. Therefore, the signalling pathway for responding to a challenge is disturbed. Apparently, due to multiple effects on beta cell structure, exposure of islets to extracellular H2O2 or STZ does not reflect effects of intracellular STZ-stimulated H2O2 generation and antioxidative responses, which are assumed to be relevant for beta cell function in vivo. Thus, applying only in vitro IRI responses of isolated islets may not be sufficient to understand in vivo mechanisms.
In summary, this study shows that MLD-STZ stimulates H2O2 generation in pancreatic islets of diabetes-susceptible C57BL/6 male mice, but does not affect the mRNA expression of the antioxidative enzymes Cu/Zn and Mn SOD, catalase, GPX1 and GPX4. However, MLD-STZ does transiently reduce GPX activity. In contrast, in female mice, MLD-STZ up-regulated all five antioxidative systems, which may confer resistance to H2O2 generation and diabetes. The results suggest that antioxidative strategies may be warranted for beta cell transplants and for prevention and intervention in patients with high risk of Type 1 diabetes.
Abbreviations
- GPX:
-
glutathione peroxidase
- H2O2 :
-
hydrogen peroxide
- HD-STZ:
-
high-dose streptozotocin
- HRP:
-
horse radish peroxidase
- IRI:
-
immunoreactive insulin
- MLD-STZ:
-
multiple low doses of streptozotocin
- NF-κB:
-
nuclear factor kappa B
- O2 −· :
-
superoxide radical
- ·OH:
-
hydroxyl radicals
- ROS:
-
reactive oxygen species
- SOD:
-
superoxide dismutase
References
Tisch R, McDevitt H (1996) Insulin-dependent diabetes mellitus. Cell 85:291–297
Rabinovitch A (1998) An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus. Diabetes Metab Rev 14:129–151
Oberley LW (1988) Free radicals and diabetes. Free Radic Biol Med 5:113–124
Eizirik DL, Pavlovic D (1997) Is there a role for nitric oxide in beta-cell dysfunction and damage in IDDM? Diabetes Metab Rev 13:293–307
Kubisch HM, Wang J, Bray TM, Phillips JP (1997) Targeted overexpression of Cu/Zn superoxide dismutase protects pancreatic beta-cells against oxidative stress. Diabetes 46:1563–1566
Xu B, Moritz JT, Epstein PN (1999) Overexpression of catalase provides partial protection to transgenic mouse beta cells. Free Radic Biol Med 27:830–837
Hotta M, Tashiro F, Ikegami H et al. (1998) Pancreatic beta cell-specific expression of thioredoxin, an antioxidative and antiapoptotic protein, prevents autoimmune and streptozotocin-induced diabetes. J Exp Med 188:1445–1451
Chen H, Carlson EC, Pellet L, Moritz JT, Epstein PN (2001) Overexpression of metallothionein in pancreatic beta-cells reduces streptozotocin-induced DNA damage and diabetes. Diabetes 50:2040–2046
Tiedge M, Lortz S, Munday R, Lenzen S (1999) Protection against the co-operative toxicity of nitric oxide and oxygen free radicals by overexpression of antioxidant enzymes in bioengineered insulin-producing RINm5F cells. Diabetologia 42:849–855
Lortz S, Tiedge M, Nachtwey T, Karlsen AE, Nerup J, Lenzen S (2000) Protection of insulin-producing RINm5F cells against cytokine-mediated toxicity through overexpression of antioxidant enzymes. Diabetes 49:1123–1130
Azevedo-Martins AK, Lortz S, Lenzen S, Curi R, Eizirik DL, Tiedge M (2003) Improvement of the mitochondrial antioxidant defense status prevents cytokine-induced nuclear factor-kappaB activation in insulin-producing cells. Diabetes 52:93–101
Tiedge M, Lortz S, Drinkgern J, Lenzen S (1997) Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes 46:1733–1742
Klinkhammer C, Popowa P, Gleichmann H (1988) Specific immunity to streptozocin. Cellular requirements for induction of lymphoproliferation. Diabetes 37:74–80
Wang Z, Gleichmann H (1998) GLUT2 in pancreatic islets: crucial target molecule in diabetes induced with multiple low doses of streptozotocin in mice. Diabetes 47:50–56
Müller A, Schott-Ohly P, Dohle C, Gleichmann H (2002) Differential regulation of Th1-type and Th2-type cytokine profiles in pancreatic islets of C57BL/6 and BALB/c mice by multiple low doses of streptozotocin. Immunobiology 205:35–50
Lgssiar A, Hassan M, Schott-Ohly P, Friesen N, Nicoletti F, Gleichmann H (2003) Recombinant human interleukin-11 inhibits NFκB and AP-1 activation in pancreatic islets and prevents diabetes induced with multiple low doses of streptozotocin. Diabetes 52 [Suppl 1]:A66
Schulze-Osthoff K, Los M, Baeuerle PA (1995) Redox signalling by transcription factors NF-kappa B and AP-1 in lymphocytes. Biochem Pharmacol 50:735–741
Chen FE, Ghosh G (1999) Regulation of DNA binding by Rel/NF-kappaB transcription factors: structural views. Oncogene 18:6845–6852
LeDoux SP, Woodley SE, Patton NJ, Wilson GL (1986) Mechanisms of nitrosourea-induced beta-cell damage. Alterations in DNA. Diabetes 35:866–872
Elsner M, Guldbakke B, Tiedge M, Munday R, Lenzen S (2000) Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin. Diabetologia 43:1528–1533
Gille L, Schott-Ohly P, Friesen N et al. (2002) Generation of hydroxyl radicals mediated by streptozotocin in pancreatic islets of mice in vitro. Pharmacol Toxicol 90:317–326
Like AA, Rossini AA (1976) Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 193:415–417
Wang Z, Dohle C, Friemann J, Green BS, Gleichmann H (1993) Prevention of high- and low-dose STZ-induced diabetes with d-glucose and 5-thio-d-glucose. Diabetes 42:420–428
Zimny S, Gogolin F, Abel J, Gleichmann H (1993) Metallothionein in isolated pancreatic islets of mice: induction by zinc and streptozotocin, a naturally occurring diabetogen. Arch Toxicol 67:61–65
Rossini AA, Like AA, Chick WL, Appel MC, Cahill GF Jr (1977) Studies of streptozotocin-induced insulitis and diabetes. Proc Natl Acad Sci USA 74:2485–2489
Wang Z, Gleichmann H (1995) Glucose transporter 2 expression: prevention of streptozotocin-induced reduction in beta-cells with 5-thio-d-glucose. Exp Clin Endocrinol Diabetes 103 [Suppl 2]:83–97
Root RK, Metcalf J, Oshino N, Chance B (1975) H2O2 release from human granulocytes during phagocytosis. I. Documentation, quantitation, and some regulating factors. J Clin Invest 55:945–955
Clifford DP, Repine JE (1984) Measurement of oxidizing radicals by polymorphonuclear leukocytes. Methods Enzymol 105:393–398
Paglia DE, Valentine WN (1967) Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 70:158–169
Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159
Schnedl WJ, Ferber S, Johnson JH, Newgard CB (1994) STZ transport and cytotoxicity. Specific enhancement in GLUT2-expressing cells. Diabetes 43:1326–1333
Wilson GL, Hartig PC, Patton NJ, LeDoux SP (1988) Mechanisms of nitrosourea-induced beta-cell damage. Activation of poly (ADP-ribose) synthetase and cellular distribution. Diabetes 37:213–216
Nukatsuka M, Sakurai H, Yoshimura Y, Nishida M, Kawada J (1988) Enhancement by streptozotocin of O2 − radical generation by the xanthine oxidase system of pancreatic beta-cells. FEBS Lett 239:295–298
Rao A (1994) NF-ATp: a transcription factor required for the co-ordinate induction of several cytokine genes. Immunol Today 15:274–281
Rossini AA, William RM, Appel MC, Like AA (1978) Sex differences in the multiple-dose streptozotocin model of diabetes. Endocrinology 103:1518–1520
Maclaren NK, Neufeld M, McLaughlin JV, Taylor G (1980) Androgen sensitization of streptozotocin-induced diabetes in mice. Diabetes 29:716–766
Schreck R, Rieber P, Baeuerle PA (1991) Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 10:2247–2258
Ho E, Bray TM (1999) Antioxidants, NFκB activation, and diabetogenesis. Proc Soc Exp Biol Med 222:205–213
Acknowledgements
This study was supported by the German Research Foundation SFB 503 “Molecular and Cellular Mediators of Exogeneous Noxae” and project B5, and by the Ministry for Health in Bonn, Germany.
Author information
Authors and Affiliations
Corresponding author
Additional information
N. T. E. Friesen and A. S. Büchau contributed equally to this work, it being part of their doctoral theses
Rights and permissions
About this article
Cite this article
Friesen, N.T.E., Büchau, A.S., Schott-Ohly, P. et al. Generation of hydrogen peroxide and failure of antioxidative responses in pancreatic islets of male C57BL/6 mice are associated with diabetes induced by multiple low doses of streptozotocin. Diabetologia 47, 676–685 (2004). https://doi.org/10.1007/s00125-004-1367-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00125-004-1367-x